- ¥3bn
- ¥2bn
- ¥5bn
- 92
- 77
- 19
- 71
Annual balance sheet for Innovation, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,998 | 2,181 | 2,370 | 3,448 | 3,741 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 500 | 704 | 652 | 701 | 917 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,590 | 3,015 | 3,085 | 4,214 | 4,976 |
| Net Property, Plant And Equipment | 22.1 | 19.2 | 16.8 | 31.3 | 74.6 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,137 | 3,769 | 3,795 | 4,678 | 8,322 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 593 | 727 | 592 | 884 | 3,748 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 623 | 790 | 634 | 1,151 | 4,935 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 2,514 | 2,979 | 3,161 | 3,527 | 3,387 |
| Total Liabilities & Shareholders' Equity | 3,137 | 3,769 | 3,795 | 4,678 | 8,322 |
| Total Common Shares Outstanding |